Shenzhen Chipscreen Biosciences Co Enterprise value
What is the Enterprise value of Shenzhen Chipscreen Biosciences Co?
The Enterprise value of Shenzhen Chipscreen Biosciences Co., Ltd. is $1.47B
What is the definition of Enterprise value?
Enterprise value is a measure of a company’s total market value. It is calculated as market capitalization with debt, minority interest, and preferred shares minus total cash and cash equivalents.
ttm (trailing twelve months)
It is a sum of claims by all claimants including creditors (secured and unsecured) and shareholders (preferred and common). Enterprise value is one of the fundamental metrics used in business valuation, financial modeling, accounting, portfolio analysis, and risk analysis. Enterprise value is more comprehensive than market capitalization, which only reflects common equity and is considered more representative of a company’s value. Enterprise value reflects the opportunistic nature of business and may change substantially over time because of both external and internal conditions.
Enterprise value can be negative if the company holds abnormally high amounts of cash that is not reflected in the market value of the stock and total capitalization. Cash is subtracted in the calculation because it reduces the net cost to a potential purchaser. The effect applies whether the cash is used to issue dividends or to pay down debt. Value of minority interest is added because it reflects the claim on assets consolidated into the firm in question. Value of associate companies is subtracted because it reflects the claim on assets consolidated into other firms. EV should also include such special components as unfunded pension liabilities, employee stock options, environmental provisions, abandonment provisions, and so on, since they also reflect claims on the company.
Enterprise value of companies in the Health Care sector on SSE compared to Shenzhen Chipscreen Biosciences Co
What does Shenzhen Chipscreen Biosciences Co do?
Shenzhen Chipscreen Biosciences Co., Ltd. engages in the research, development, and sale of original small molecule drugs. The company develops precursor compounds and original new drug product lines that are in various research phase of the specific global intellectual property protection in three areas, such as cancer, metabolic diseases, and autoimmune diseases. Shenzhen Chipscreen Biosciences Co., Ltd. was founded in 2001 and is based in Shenzhen, China.
Companies with enterprise value similar to Shenzhen Chipscreen Biosciences Co
- Lerthai has Enterprise value of $1.47B
- Costa has Enterprise value of $1.47B
- Garrett Motion has Enterprise value of $1.47B
- First Busey has Enterprise value of $1.47B
- PC Connection has Enterprise value of $1.47B
- Blue Prism Plc has Enterprise value of $1.47B
- Shenzhen Chipscreen Biosciences Co has Enterprise value of $1.47B
- CRCAM du Languedoc has Enterprise value of $1.47B
- Yatsen Ltd has Enterprise value of $1.48B
- P10 has Enterprise value of $1.48B
- Dicker Data has Enterprise value of $1.48B
- Oxford Instruments plc has Enterprise value of $1.48B
- Hope Bancorp Inc has Enterprise value of $1.48B